Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Profound Medical Corp T.PRN

Alternate Symbol(s):  PROF

Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. TULSA-PRO is designed to provide customizable and predictable radiation-free ablation of a surgeon-defined prostate volume while protecting the urethra and rectum. TULSA-PRO has the potential to be a flexible technology in customizable prostate ablation, including intermediate stage cancer, localized radio-recurrent cancer, retention and hematuria palliation in locally advanced prostate cancer and the transition zone in large volume benign prostatic hyperplasia. It is also commercializing Sonalleve, which is a therapeutic platform for the treatment of uterine fibroids and palliative pain treatment of bone metastases.


TSX:PRN - Post by User

Post by MrMugsyon Apr 21, 2021 9:58pm
251 Views
Post# 33042467

Bloom Burton ...

Bloom Burton ...A few things I noticed ...

Reimbursement C-code seems to be working ... dozens of customers used it to date.

For permaent reimbursement ... will have all the data we need by yearend and then it's a 2 year process after submitting.

With "pay per service" PRN's customers get "Genius Services" bundled in - includes software updates (complete support sytem).

Not only is the cost of the operation cheaper than surgery or radiation, it is safer and you get back to work faster with less discomfort.

Small molecule therapies are not a threat - none in P3 for prostate.  In the future, could see a combination therapy with small molecules.  Would be open to that.

Knight has Canadian rights and if you have any questions re. Canada, you should ask them.  Should have one system running near Toronto this year.  This could be the seed to get things going in Canada
(Note:  I spoke with Knight a while back and they also mentioned Sunnybrook as the location - thinking that customer demand will eventually drive the product into other areas of Canada).

END
<< Previous
Bullboard Posts
Next >>